ZIMLAB2023-07-012023-09-30 ZIMLAB2023-07-012023-09-30 ZIMLAB2023-07-012023-09-30in-bse-fin:OneOperatingExpenses01Member ZIMLAB2023-07-012023-09-30in-bse-fin:FourOperatingExpenses01Member ZIMLAB2023-09-30 iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 541400 ZIMLAB NA Zim Laboratories Limited Equity 2023-04-01 2024-03-31 2023-11-01 2023-10-21 INR Lakhs Half yearly 18:00:00 19:30:00 2023-11-01 2023-11-01 true Cash Flow Indirect Not applicable Single segment Pharmaceutical Industry 2023-07-01 2023-09-30 Unaudited Standalone 852595000.00 14214000.00 866809000.00 409635000.00 20404000.00 -30840000.00 122449000.00 12169000.00 37169000.00 241326000.00 812312000.00 54497000.00 0.00 54497000.00 8185000.00 4533000.00 12718000.00 0.00 41779000.00 0.00 0.00 0.00 0.00 41779000.00 -1155000.00 40624000.00 40624000.00 0.00 487258000.00 10 0.86 0.86 0.00 0.00 0.86 0.86 0.00 0.02 0.05 Notes : 1) The above results were reviewed and recommended by the Audit Committee and approved by the Board of Directors at their respective meetings held on 01 November 2023. There are no qualifications in the limited review report issued for the quarter and half year ended 30 September 2023. 2) These financial results have been prepared in accordance with the recognition and measurement principles of applicable Indian Accounting Standard ('Ind AS') notified under the Companies (Indian Accounting Standards) Rules, 2015 (as amended), as prescribed under Section 133 of the Companies Act, 2013 and other accounting principles generally accepted in India and is in compliance with the presentation and disclosure requirements of Regulation 33 of the Listing Regulations and guidelines issued by the Securities and Exchange Board of India (SEBI). 3) The Company is principally engaged in a single business segment which is pharmaceuticals . 4) The Company had entered into an escrow agreement in 2017 (with subsequent renewals) with one of its shareholders, wherein the shareholder had provided his holdings to the extent of 30 Lakhs equity shares (including 25 Lakhs bonus shares) as a security towards realization of covered trade receivables. During the previous quarter, the equity shares have been liquidated at a gross consideration of Rs. 3,067.58 lakhs. Accordingly, the net amount realised (which is gross consideration as reduced by the applicable taxes and charges) has been recognised as a credit to the 'Retained Earnings' under 'Other equity' in accordance with the guidance under Ind AS 1- Presentation of Financial Statements, which states that transactions with shareholders (being the owners of Company), shall be recognized under Equity. 5) During the quarter ended 31 December 2022, the Company allotted 32,483,876 equity shares of face value Rs. 10 each as fully paid up bonus shares by capitalisation of securities premium aggregating to Rs. 3,248.39 lakhs, pursuant to an ordinary resolution passed by the shareholders in the extra ordinary general meeting on 12 December 2022. The Company has issued two bonus equity shares against one equity share held by its shareholders. Earnings per share for the quarter and period ended 30 September 2022 have been adjusted towards bonus shares issued. Place: Toronto, Canada Anwar S. Daud Date: 01 November 2023 Managing Director Single segment 2023-04-01 2023-09-30 Unaudited Standalone 1522666000.00 20538000.00 1543204000.00 727036000.00 26713000.00 -43405000.00 243689000.00 29511000.00 73765000.00 433624000.00 1490933000.00 52271000.00 0.00 52271000.00 8185000.00 3737000.00 11922000.00 0.00 40349000.00 0.00 0.00 0.00 0.00 40349000.00 -2309000.00 38040000.00 38040000.00 0.00 487258000.00 10 0.83 0.83 0.00 0.00 0.83 0.83 0.00 0.02 0.03 Other Expenses 241326000.00 Other Expenses 433624000.00 1043639000.00 408901000.00 0.00 0.00 40533000.00 105102000.00 0.00 0.00 81759000.00 0.00 0.00 6915000.00 88674000.00 0.00 135774000.00 1822623000.00 660755000.00 0.00 702692000.00 3480000.00 21139000.00 317000.00 2733000.00 730361000.00 0.00 375806000.00 1766922000.00 0.00 0.00 3589545000.00 487258000.00 1706588000.00 2193846000.00 2193846000.00 378733000.00 0.00 6726000.00 385459000.00 0.00 50821000.00 0.00 0.00 436280000.00 222299000.00 529569000.00 92399000.00 844267000.00 35812000.00 6493000.00 72847000.00 0.00 959419000.00 0.00 0.00 1395699000.00 3589545000.00 29511000.00 -123693000.00 188338000.00 0.00 0.00 -1856000.00 1105000.00 -35150000.00 0.00 -63634000.00 0.00 0.00 -24142000.00 73765000.00 0.00 0.00 0.00 -6860000.00 0.00 -6913000.00 0.00 282000.00 0.00 0.00 0.00 0.00 -3780000.00 0.00 0.00 26409000.00 78680000.00 0.00 0.00 0.00 -62456000.00 0.00 141136000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 321600000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 60000.00 148000.00 0.00 -8892000.00 0.00 -330284000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 211355000.00 198560000.00 0.00 8325000.00 0.00 36964000.00 0.00 214024000.00 181530000.00 -7618000.00 0.00 -7618000.00 11098000.00 3480000.00 -1629000.00 -3257000.00 -474000.00 -948000.00 0.00 0.00